AVO

Hardman & Co

Advanced Oncotherapy Preparing for commercialisation

Advanced Oncotherapy (LON:AVO) goal is to deliver an affordable and novel proton beam therapy system (PBT), based on state-of-the-art technology developed originally at the world-renowned CERN. 2018 was characterised by

Hardman & Co

Advanced Oncotherapy Four components integrated

Advanced Oncotherapy (LON:AVO)  goal is to deliver an affordable and novel proton therapy system (PT), based on state-of-the-art technology developed originally at the world-renowned CERN. Achievement of major technical milestones

Advanced Oncotherapy Plc

University Hospitals hitting mark with proton therapy

While some proton therapy centres across the country have reportedly struggled to stay profitable, officials at University Hospitals say they’ve found the “sweet spot” two years after the Cleveland-based health

Advanced Oncotherapy Plc

Advanced Oncotherapy a Significant Year

Nicolas Serandour, CEO of Advanced Oncotherapy, said: “The technological development of our LIGHT system remains on-track and we continue to proceed with a significantly reduced overall technology risk profile. Similarly

Advanced Oncotherapy Plc

CERN Technology Next Generation Cancer Treatment

STFC and Advanced Oncotherapy (LON:AVO) are collaborating in the construction of a proton therapy assembly and test facility at STFC’s Daresbury Laboratory, that will build on the technology at the

Advanced Oncotherapy Plc

Proton Beam therapy to come to Isarel

The deputy Health Minister Yaakov Litzman has ordered his ministry to finalise plans to establish a Proton Beam Therapy center in Israel. The announcement came after Litzman returned to Israel

STRIX GROUP PLC ORD 1P
Strix Group plc CEO Mark Bartlett discusses the company's focus on safety controls, global reach, innovation, and growth opportunities for investors.
Firering Strategic MineralS PLC
Learn about Firering Strategic Minerals plc's operations and future plans from an exclusive interview with their Independent Non-Executive Director, Vassilios Carellas.
Pulsar Helium Inc
Discover insights into the helium sector as Stephane Foucard delves into the projects of junior companies, assessing key criteria for commercial viability.
Golden Matrix Group Inc
Golden Matrix Group Inc. CEO Brian Goodman discusses revenue growth, acquisitions, and global markets in an exclusive interview with DirectorsTalk.
XP Factory plc
XP Factory plc's CEO discusses financial highlights, growth targets, and a £10 million credit facility with Barclays in an exclusive interview with DirectorsTalk.
Fidelity Special Values
The British pound hits a one-week high against the US dollar amid tariff strategies and inflation concerns, reflecting global economic sensitivity.
Fidelity Asian Values
Asian markets surged after Wall Street gains, with regional equities rising in Japan, South Korea, and Australia. Dollar steadied amid tariff relief and geopolitical tensions.
Fidelity China Special Situations
China's stock markets surge on strong AI and semiconductor gains, contrasting Hong Kong's struggles with US sanctions. Fidelity’s FCSS seeks opportunities amidst the volatility.
Fidelity Japan Trust
Discover why Japanese equities are set for a stellar 2025, driven by corporate earnings, governance reforms, and market optimism. Strategic insights here.
Fidelity European Trust
European markets open optimistically post-Microsoft's AI investment, with focus on global data releases and tech sector resilience. STOXX 600 up 0.2%.
JPMorgan European Discovery Trust
European shares surge as tech and banking stocks lead gains amid economic updates. STOXX 600 rises 0.3% on strong Wall Street close, pivotal data ahead.